Phio Pharmaceuticals director David H. Deming acquires $9,822.60 in common shares
PHIO•Director David H. Deming purchased 12,000 Phio Pharmaceuticals common shares for a total of $9,822.60, raising his directly held beneficial ownership to 61,800 shares.




